Results 11 to 20 of about 139,987 (302)

Peripheral T-cell lymphoma of the eyelid

Clinical Ophthalmology, 2009
Makoto Ishikawa, Hiroshi Watabe, Masahiro Hayakawa, Takeshi YoshitomiDepartment of Ophthalmology, Akita University Faculty of Medicine, Akita, JapanPurpose: To report a case of a 25-year-old woman with previously treated peripheral T-cell lymphoma (PTCL)
Makoto Ishikawa, Hiroshi Watabe, Masahiro Hayakawa, et al   +3 more
doaj   +5 more sources

Peripheral T cell lymphoma: Not otherwise specified

Indian Journal of Dermatology, 2015
Peripheral T cell lymphoma (PTCL) is a heterogeneous group of hematological tumors originating from mature T cells, which constitutes less than 15% of all non-Hodgkins lymphomas in adults.
Anusha H Pai, Anne George, Deepa Adiga, Banavasi S Girisha   +3 more
doaj   +3 more sources

Peripheral T cell lymphoma: clinical utility of romidepsin

Blood and Lymphatic Cancer: Targets and Therapy, 2012
Jasmine Zain, Kathryn SaweyNYU Langone Medical Center, New York, USAIntroduction: Direct therapeutic targets, such as aberrant tumor cell genes and tumor cell markers, have been the focus of cancer treatment for more than 50 years.
Sawey K, Zain J
doaj   +1 more source

Peripheral T cell lymphoma.

Journal of Clinical Oncology, 1987
Thirty-one Chinese patients with peripheral T cell lymphoma (PTCL) were reviewed. Using the modified Japanese Lymphoma Group classification, there were nine (29%) of the pleomorphic type, 16 (52%) immunoblastic lymphadenopathy (IBL)-like, two (7%) T-zone lymphoma, and one (3%) Lennert's lymphoepithelioid type. Three (9%) were not classifiable.
R, Liang, D, Todd, T K, Chan, K L, Wong, F, Ho, S L, Loke   +5 more
openaire   +3 more sources

Peripheral T-cell lymphoma [PDF]

Cancer, 1989
Peripheral T-cell lymphoma is the most common type of T-cell lymphoma seen in adults in the United States. Clinical data were reviewed from 134 cases of peripheral T-cell lymphoma diagnosed in three centers. The median age of the patients was 57 years (range, 4-97 years), 59% were male, and 36 patients (27%) had a history of a preceding disorder of the
James O. Armitage, John P. Greer, Alexandra M. Levine, Dennis D. Weisenburger, Silvia C. Formenti, Martin Bast, Sue Conley, Jene Pierson, James Under, John B. Cousar, Bharat N. Nathwani   +10 more
openaire   +2 more sources

What's new in peripheral T‐cell lymphomas [PDF]

Hematological Oncology, 2021
AbstractPeripheral T‐cell lymphomas (PTCLs) are a rare, heterogeneous group of hematological malignancies with extremely poor prognosis for almost all subtypes. The diverse clinicopathological features of PTCLs make accurate diagnosis, prognosis, and choice of optimal treatment strategies difficult.
Luminari S., Skrypets T.
openaire   +2 more sources

Peripheral T cell lymphoma in Asia [PDF]

International Journal of Hematology, 2014
Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of mature T- and NK-cell neoplasms, the incidence of which is higher in Asian countries than in Western countries. Although its etiology is mainly unknown, several risk factors (such as genetic factors, abnormal immunity, environmental factors, and infectious causes) have been proposed.
Sanghui, Park, Young Hyeh, Ko
openaire   +2 more sources

Peripheral T-cell lymphomas

Annals of Oncology, 1991
The development of T cells from stem (progenitor) cells to effector cells results from a two-wave process of proliferation and differentiation. The cells of the first differentiation wave are the precursor T cells, and those of the second differentiation wave are peripheral T cells.
H, Stein, D, Dienemann, F, Dallenbach, M, Kruschwitz   +3 more
openaire   +2 more sources

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

, 2014
Peripheral T-cell lymphoma (PTCL) encompasses a heterogeneous group of neoplasms with generally poor clinical outcome. Currently 50% of PTCL cases are not classifiable: PTCL-not otherwise specified (NOS).
Connors, J.M., Wilcox, R.A., Staudt, L.M., Rimsza, L.M., Rosenwald, A., Smith, L., the International Peripheral T-cell Lymphoma, Project, Gascoyne, R.D., Iqbal, J., Braziel, R.M., Lim, S.T., Au, W.Y., Wang, C., Geissinger, E., Gaulard, P., Tan, S.Y., Nakamura, S., Vose, J., Seto, M., Weisenburger, D.D., Delabie, J., Lymphoma Leukemia Molecular Profiling, Project, Jaffe, E.S., Cook, J.R., Guo, S., Armitage, J., Martinez, A., Berger, F., Chan, W.C., Greiner, T.C., Tubbs, R.R., Campo, E., Pileri, S.A., Wright, G., Teh, B.T., Ott, G., Piccaluga, P.P., de Leval, L.   +37 more
core   +2 more sources

Peripheral T-cell lymphoma

Blood, 2011
AbstractPeripheral T-cell lymphomas (PTCLs) are a heterogeneous group of clinically aggressive diseases associated with poor outcome. Studies that focus specifically on PTCL are emerging, with the ultimate goal of improved understanding of disease biology and the development of more effective therapies.
Foss F. M., ZINZANI, PIER LUIGI, Vose J. M. s, Gascoyne R. D., Rosen S. T., Tobinai K.   +5 more
openaire   +4 more sources